期刊
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
卷 213, 期 4, 页码 S163-S172出版社
MOSBY-ELSEVIER
DOI: 10.1016/j.ajog.2015.05.057
关键词
adverse pregnancy outcome; C19MC; exosomes; miRNA; placenta; pregnancy complications; primate-specific miRNA; trophoblast; trophoblast-specific miRNA
资金
- Pennsylvania Department of Health Research Formula Funds Grant [0863906]
- National Institutes of Health [R01HD065893, R21HD071707, R01AI081759, R01HD075665]
MicroRNAs (miRNAs) constitute a large family of small noncoding RNAs that are encoded by the genomes of most organisms. They regulate gene expression through post-transcriptional mechanisms to attenuate protein output in various genetic networks. The discovery of miRNAs has transformed our understanding of gene regulation and sparked intense efforts intended to harness their potential as diagnostic markers and therapeutic tools. Over the last decade, a flurry of studies has shed light on placental miRNAs but has also raised many questions regarding the scope of their biologic action. Moreover, the recognition that miRNAs of placental origin are released continually in the maternal circulation throughout pregnancy suggested that circulating miRNAs might serve as biomarkers for placental function during pregnancy. Although this generated much enthusiasm, recently recognized challenges have delayed the application of miRNA-based biomarkers and therapeutics in clinical practice. In this review, we summarize key findings in the field and discuss current knowledge related to miRNAs in the context of placental biology.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据